Director, Cost Accounting

The role

The Director, Inventory / Cost Accounting leads inventory and cost accounting strategy and establishes financial infrastructure for commercial launch and portfolio growth. This person develops cost models, manages inventory valuation, and provides strategic guidance on product costs and gross margin.

What you will do

• Develop, implement, and maintain cost models for commercial products manufactured through third-party CMOs/CDMOs
• Establish and maintain bill of materials and routing cost structures
• Perform periodic cost updates and manufacturing/production variance analysis
• Analyze and report on cost of goods sold (COGS)
• Own inventory accounting for raw materials, work-in-process, clinical supply, and finished goods
• Direct the period-end inventory and accounting close
• Manage inventory reserve methodology and periodic assessments
• Manage physical inventory counts and cycle count programs across CMOs, CDMOs, and 3PL providers
• Serve as the finance leader for cost-related aspects of CMO/CDMO relationships
• Establish and maintain a scalable control environment complying with U.S. GAAP and SOX requirements

Required qualifications

• Bachelor's degree in Accounting, Finance, or related field
• CPA required
• 10+ years of progressive cost accounting experience
• 3-5 years in a leadership/managerial capacity
• Direct experience with cost accounting in a pharmaceutical, biotech, or life sciences manufacturing environment
• Experience managing cost accounting for products manufactured through CMOs/CDMOs
• Strong knowledge of U.S. GAAP as it relates to inventory, standard costing, and COGS
• Experience with ERP systems (e.g., NetSuite) and cost accounting/inventory modules
• Advanced Excel skills
• Experience supporting a commercial product launch and scaling cost accounting processes
• Experience with SOX compliance and public company reporting requirements

Nice to have

• experience building cost models

About the company

Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. The company is advancing clinical and preclinical programs for various muscular diseases.